Aveo shares drop with uncertainty of NDA submission for Fotivda

Aveo Pharmaceuticals Inc. (NASDAQ:AVEO) lost $1.07 (60%) to $0.70 on Jan. 31 after the company said it will not submit an NDA to

Read the full 236 word article

User Sign In